פרדקסה 75 Izraelis - hebrajų - Ministry of Health

פרדקסה 75

boehringer ingelheim israel ltd. - dabigatran etexilate as mesilate - קפסולות - dabigatran etexilate as mesilate 75 mg - dabigatran etexilate - dabigatran etexilate - primary prevention of venous thromboembolic events in adult patients who have undergone elective total hip replacement surgery or total knee replacement surgery.

פרדקסה 110 Izraelis - hebrajų - Ministry of Health

פרדקסה 110

boehringer ingelheim israel ltd. - dabigatran etexilate as mesilate - קפסולות - dabigatran etexilate as mesilate 110 mg - dabigatran etexilate - dabigatran etexilate - primary prevention of venous thromboembolic events in adult patients who have undergone elective total hip replacement surgery or total knee replacement surgery.prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation.

פרדקסה 75 Izraelis - hebrajų - Ministry of Health

פרדקסה 75

boehringer ingelheim israel ltd. - dabigatran etexilate as mesilate - קפסולות - dabigatran etexilate as mesilate 75 mg - dabigatran etexilate

פרדקסה 75 Izraelis - hebrajų - Ministry of Health

פרדקסה 75

boehringer ingelheim israel ltd. - dabigatran etexilate as mesilate - קפסולות - dabigatran etexilate as mesilate 75 mg - dabigatran etexilate

אטרובנט Izraelis - hebrajų - Ministry of Health

אטרובנט

boehringer ingelheim israel ltd. - ipratropium bromide - משאף - ipratropium bromide 0.02 mg - ipratropium bromide - ipratropium bromide - for the relief of symptoms of reversible bronchospasm associated with asthma, chronic bronchitis and emphysema.

אירובנט Izraelis - hebrajų - Ministry of Health

אירובנט

boehringer ingelheim israel ltd. - ipratropium bromide - תמיסה למנשם - ipratropium bromide 0.25 mg/ml - ipratropium bromide

סיפרול 1 מג Izraelis - hebrajų - Ministry of Health

סיפרול 1 מג

boehringer ingelheim israel ltd. - pramipexole dihydrochloride monohydrate - טבליה - pramipexole dihydrochloride monohydrate 1 mg - pramipexole - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with lovodopa.

סיפרול 0.25 מג Izraelis - hebrajų - Ministry of Health

סיפרול 0.25 מג

boehringer ingelheim israel ltd. - pramipexole dihydrochloride monohydrate - טבליה - pramipexole dihydrochloride monohydrate 0.25 mg - pramipexole - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with lovodopa. for symptomatic treatment of moderate to severe idiopathic restless legs syndrome.

אקטיליז 20 מג Izraelis - hebrajų - Ministry of Health

אקטיליז 20 מג

boehringer ingelheim israel ltd. - alteplase - אבקה וממס להכנת תמיסה להזרקה\אינפוזיה - alteplase 20 mg/vial - enzymes - acute myocardial infarction: actilyse is indicated for use in the management of acute myocardial infarction (ami) in adults for the lysis of thrombi obstructing coronary arteries, the reduction of infarct size, the improvement of ventricular function, the reduction of the incidence of congestive heart failure and the reduction of mortality associated with ami. treatment should be initiated as soon as possible after the onset of ami symptoms. massive pulmonary embolism with hemodynamic deprivation : actilyse is indicated in the management of acute massive pulmonary embolism (pe) in adults : - for the lysis of acute pulmonary emboli, defined as obstruction of blood flow to a lobe or multiple segments of the lung, and - for the lysis of pulmonary emboli accompanied by unstable hemodynamics e.g. failure to maintain blood pressure without supportive measures. the diagnosis should be confirmed by objective means, such as pulmonary angiography or noninvasive procedures such as lung scanning. for fibrinolytic treatme

ספיולטו רספימט Izraelis - hebrajų - Ministry of Health

ספיולטו רספימט

boehringer ingelheim israel ltd. - olodaterol as hydrochloride; tiotropium bromide as monohydrate - תמיסה לשאיפה - olodaterol as hydrochloride 2.5 mcg; tiotropium bromide as monohydrate 2.5 mcg - vilanterol and umeclidinium bromide